Literature DB >> 21742229

Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders.

C Lamour1, A Bergeron.   

Abstract

INTRODUCTION: Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders are not rare but remain little known to respiratory physicians who may be confronted with various clinical pictures corresponding to different pathophysiological causes.
BACKGROUND: The few data in the literature only relate to isolated cases or small series. The non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders can be classified into several clinical entities: tumour syndrome, pulmonary fibrosis or diffuse infiltrating pneumonia, autoimmune reactions including vasculitis, Sweet syndrome, organizing pneumonia, pulmonary alveolar proteinosis, pleural effusion and pulmonary arterial hypertension. The diagnosis is provided by the histology and management of these complications depends on the underlying pathology. VIEWPOINTS AND
CONCLUSION: Myelodysplastic syndromes and myeloproliferative disorders are entities which are becoming better characterized and understood. Better knowledge of the pathophysiological mechanisms involved in these complications should improve their diagnosis and their management, which still remains complex.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2011        PMID: 21742229     DOI: 10.1016/j.rmr.2009.04.001

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  4 in total

1.  Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study.

Authors:  Amy M Linabery; Anna E Prizment; Kristin E Anderson; James R Cerhan; Jenny N Poynter; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

2.  Pulmonary extramedullary hematopoiesis involving the pulmonary artery.

Authors:  Varun Monga; Margarida Silverman
Journal:  Hematol Rep       Date:  2015-03-24

3.  Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation.

Authors:  Kodappully S Siveen; Kirti S Prabhu; Aeijaz S Parray; Maysaloun Merhi; Abdelilah Arredouani; Mohamed Chikri; Shahab Uddin; Said Dermime; Ramzi M Mohammad; Martin Steinhoff; Ibrahim A Janahi; Fouad Azizi
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

4.  Characteristics and Follow-Up of Organizing Pneumonia Associated with Haematological Malignancies.

Authors:  Huihui Zeng; Yiming Ma; Xue He; Shan Cai; Ping Chen; Yan Chen; Hong Luo
Journal:  Int J Gen Med       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.